_1777294237270_124456903.png&w=48&q=75){kind=small}
Al-Majid for Oud bids for Al-Safa Pharmaceuticals
Almajd for Oud has announced the signing of a non-binding offer to acquire Al Safa Pharmaceuticals and Medical Supplies, as well as several entities and commercial assets across the Gulf region, with a total value of 392 million Saudi Riyals. The offer includes full acquisition of the companies and assets in Saudi Arabia, the UAE, Qatar, Bahrain, and Oman, with compensation provided through a combination of cash and new shares. The deal is subject to various legal and financial conditions and verifications, and it requires regulatory approvals before the transaction can be finalized.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)